A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma.
Fredrik I ThegeDhwani N RupaniBhargavi Brahmendra BarathiSara L ManningAnirban MaitraAndrew D RhimSonja M WörmannPublished in: Cancer research (2022)
A streamlined platform for programmable CRISPR gene activation enables rapid evaluation and functional validation of putative oncogenes in vivo.